% Adjusted EBITDA(1) 217 444 -51% 310 -30% Adjusted EBITDA Margin (%) 7.7% 9.6% -1.9% 8.5% -0.8% Net Profit 22 64 -66% 171 -87% Extra item - - n.a. 272(2) n.a. Net Profit 22 64 -66% 443 -95% EPS (Baht/share
Power BI visualization of our results can be accessed at http://bit.ly/2PjAo2L. Keywords: equity mutual funds, risk-adjusted return, flow-performance relationship JEL Classification Code: G11 http
the transaction, Modern Company must adjust its business structure by buying out land and factory buildings as well as adjust all existing assets and liabilities of the company except tools, machinery
. With deducting the effect of Stock Loss & NRV, the Company had Adjusted EBITDA of THB 254 million, an increase of 74% from 2Q2019. All resulting in this quarter, the Company posted the net loss of THB
Administration (CFDA) at the beginning of 2 0 1 8 as the Company had to redesign its packaging to comply with the requirements of the license. Furthermore, the Company also found it necessary to adjust its sales
issued from China Food and Drug Administration (CFDA) at the beginning of 2018 as the Company had to redesign its packaging to comply with the requirements of the license and adjust its sales structures
(loss) of the year 464.4 29.2% (299.9) (11.4%) (164.6%) Adjusted items Net unrealized loss on exchange rate - - 29.0 1.1% - Non-recurring items2 235.5 14.8% (261.8) (9.9%) (211.2) Adjusted EBITDA3 715.8
) & NRV -233 -33 606% -62 276% Adjusted EBITDA(1) 444 345 29% 449 -1% Adjusted EBITDA Margin (%) 9.6% 8.1% 1.5% 8.6% 1.0% Net Profit 64 145 -56% 251 -75% EPS (Baht/share) 0.06 0.20 -70% 0.24 -75% Note : (1
market place. In addition, it is an important mean whereby prices of the underlying products can adjust with greater efficiency and better direction so that the market can function with greater accuracy
price in Q2/2019 compared to Q2/2018 adjusted downward by 4.52 $/BBL due to anxieties expressed in regards to global economic recession, which is a result from the trade war between the US and China